Literature DB >> 24491280

Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells.

Tobias Lange1, Timur R Samatov2, Alexander G Tonevitsky3, Udo Schumacher4.   

Abstract

Aberrant glycosylation of cell surface glycoproteins acquired during malignant progression is a common characteristic of human cancer cells. Several biological processes and molecular mechanisms relevant for tumour progression are accompanied by altered mRNA expression levels of certain glycosyltransferases resulting in unusual ratios of common glycoconjugates present in a cancer cell's glycocalyx or even in the development of unusual, cancer-characterizing carbohydrates. This mini-review aims to give a concise overview on the current knowledge of the functional relevance of altered O- and N-glycans during two critical steps of tumour progression: (I) epithelial-to-mesenchymal transition of primary tumour cells during intravasation and (II) adhesion of circulating tumour cells towards the vascular wall during extravasation at a distant metastatic site. Characteristic lectin binding patterns reflecting these glycosylation changes and the resulting prognostic impact of certain lectin binding sites in different neoplasias are reviewed as well.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aberrant glycosylation; Adhesion; Cancer metastasis; Epithelial–mesenchymal transition; Lectin binding

Mesh:

Substances:

Year:  2014        PMID: 24491280     DOI: 10.1016/j.carres.2014.01.010

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  16 in total

Review 1.  Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer.

Authors:  Jos P M van Putten; Karin Strijbis
Journal:  J Innate Immun       Date:  2017-01-05       Impact factor: 7.349

2.  Expression of CD44 Isoforms in Tumor Samples and Cell Lines of Human Colorectal Cancer.

Authors:  V O Novosad; I S Polikanova; E A Tonevitsky; D V Maltseva
Journal:  Bull Exp Biol Med       Date:  2022-05-27       Impact factor: 0.804

3.  Aberrant Protein Glycosylation in Brain Cancers, with Emphasis on Glioblastoma.

Authors:  Livia Rosa-Fernandes; Sueli Mieko Oba-Shinjo; Janaina Macedo-da-Silva; Suely Kazue Nagahashi Marie; Giuseppe Palmisano
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  N-Acetylglucosaminyltransferase III (GnT-III) but not N-Acetylgalactosaminyltransferase-6 and 8 are Differentially Expressed in Invasive and In Situ Ductal Carcinoma of the Breast.

Authors:  Antônio Felix da Silva Filho; Gabriela Souto Vieira-de-Mello; Petra Barros Dos Santos; Moacyr Jesus Barreto de Melo Rêgo; Alfredo Ribeiro-Silva; Eduardo Isidoro Carneiro Beltrão
Journal:  Pathol Oncol Res       Date:  2019-01-28       Impact factor: 3.201

Review 5.  Advances in the Immunomodulatory Properties of Glycoantigens in Cancer.

Authors:  Valeria da Costa; Teresa Freire
Journal:  Cancers (Basel)       Date:  2022-04-07       Impact factor: 6.575

6.  EMT and tumor metastasis.

Authors:  Sarah Heerboth; Genevieve Housman; Meghan Leary; Mckenna Longacre; Shannon Byler; Karolina Lapinska; Amber Willbanks; Sibaji Sarkar
Journal:  Clin Transl Med       Date:  2015-02-26

Review 7.  Novel clinical therapeutics targeting the epithelial to mesenchymal transition.

Authors:  Anai N Kothari; Zhiyong Mi; Matthew Zapf; Paul C Kuo
Journal:  Clin Transl Med       Date:  2014-10-15

8.  Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts.

Authors:  James R Hernandez; John J Kim; James E Verdone; Xin Liu; Gonzalo Torga; Kenneth J Pienta; Steven M Mooney
Journal:  Med Oncol       Date:  2015-04-09       Impact factor: 3.064

9.  Effect of the Expression of ELOVL5 and IGFBP6 Genes on the Metastatic Potential of Breast Cancer Cells.

Authors:  Sergey Nikulin; Galina Zakharova; Andrey Poloznikov; Maria Raigorodskaya; Daniel Wicklein; Udo Schumacher; Stepan Nersisyan; Jonas Bergquist; Georgy Bakalkin; Lidiia Astakhova; Alexander Tonevitsky
Journal:  Front Genet       Date:  2021-06-02       Impact factor: 4.599

10.  GP73 N-glycosylation at Asn144 reduces hepatocellular carcinoma cell motility and invasiveness.

Authors:  Kai Jiang; Wei Li; Qinle Zhang; Guoquan Yan; Kun Guo; Shu Zhang; Yinkun Liu
Journal:  Oncotarget       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.